Terms: = Lung cancer AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1
952 results:
1. Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer.
Han R; Guo H; Shi J; Zhao S; Jia Y; Liu X; Liu Y; Cheng L; Zhao C; Li X; Zhou C
BMC Med; 2024 Apr; 22(1):174. PubMed ID: 38658988
[TBL] [Abstract] [Full Text] [Related]
2. Promoting the Anticancer Activity with Multidentate Furan-2-Carboxamide Functionalized Aroyl Thiourea Chelation in Binuclear Half-Sandwich Ruthenium(II) Complexes.
Thangavel SK; Mohamed Kasim MS; Rengan R
Inorg Chem; 2024 Apr; 63(16):7520-7539. PubMed ID: 38590210
[TBL] [Abstract] [Full Text] [Related]
3. Grafted Sertoli Cells Exert Immunomodulatory Non-Immunosuppressive Effects in Preclinical Models of Infection and cancer.
Chiappalupi S; Salvadori L; Borghi M; Mancuso F; Pariano M; Riuzzi F; Luca G; Romani L; Arato I; Sorci G
Cells; 2024 Mar; 13(6):. PubMed ID: 38534388
[TBL] [Abstract] [Full Text] [Related]
4. Recent development of vegfr small molecule inhibitors as anticancer agents: A patent review (2021-2023).
Zeng J; Deng Q; Chen Z; Yan S; Dong Q; Zhang Y; Cui Y; Li L; He Y; Shi J
Bioorg Chem; 2024 May; 146():107278. PubMed ID: 38484586
[TBL] [Abstract] [Full Text] [Related]
5. Targeting oncogenic kinases: Insights on FDA approved tyrosine kinase inhibitors.
Hussain S; Mursal M; Verma G; Hasan SM; Khan MF
Eur J Pharmacol; 2024 May; 970():176484. PubMed ID: 38467235
[TBL] [Abstract] [Full Text] [Related]
6. Circulating Tumor DNA Dynamics Fail to Predict Efficacy of Poly(ADP-ribose) Polymerase/vegfr Inhibition in Patients With Heavily Pretreated Advanced Solid Tumors.
Hu Y; Narayan A; Xu Y; Wolfe J; Vu D; Trinh T; Kantak C; Ivy SP; Eder JP; Deng Y; LoRusso P; Kim JW; Patel AA
JCO Precis Oncol; 2024 Feb; 8():e2300289. PubMed ID: 38412387
[TBL] [Abstract] [Full Text] [Related]
7. The inhibitory effect of apatinib on different small cell lung cancer cells and in lung cancer-bearing mice and patients.
Liu M; Li H; Guo R; Yu X; Li Y
Clin Respir J; 2024 Feb; 18(2):e13738. PubMed ID: 38403875
[TBL] [Abstract] [Full Text] [Related]
8. vegfr affects miR-3200-3p-mediated regulatory T cell senescence in tumour-derived exosomes in non-small cell lung cancer.
Hui K; Dong C; Hu C; Li J; Yan D; Jiang X
Funct Integr Genomics; 2024 Feb; 24(2):31. PubMed ID: 38363405
[TBL] [Abstract] [Full Text] [Related]
9. Hexane Fraction of
Park HJ; Jeong JH; Choi YH; Park SH
Molecules; 2024 Jan; 29(3):. PubMed ID: 38338342
[TBL] [Abstract] [Full Text] [Related]
10. NKX2-1-AS1 promotes the lymphangiogenesis of lung adenocarcinoma through regulation of ERG-mediated FABP4.
Tao T; Chen H; Xu Q; Li Z; Chen X; Zhou X; Luo W
Tissue Cell; 2024 Apr; 87():102314. PubMed ID: 38309204
[TBL] [Abstract] [Full Text] [Related]
11. Chemosensitization of non-small cell lung cancer to sorafenib via non-hydroxamate s-triazinedione-based MMP-9/10 inhibitors.
Khalil HH; El-Sheshtawy MM; Khattab SN; Abu-Serie MM; Shehat MG; Teleb M; Haiba NS
Bioorg Chem; 2024 Mar; 144():107155. PubMed ID: 38306827
[TBL] [Abstract] [Full Text] [Related]
12. Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial.
Beckermann KE; Asnis-Alibozek AG; Atkins MB; Escudier B; Hutson TE; Kasturi V; McDermott DF; Pal SK; Porta C; Rini BI; Verzoni E
Oncologist; 2024 Mar; 29(3):254-262. PubMed ID: 38262444
[TBL] [Abstract] [Full Text] [Related]
13. β-Caryophyllene Inhibits Endothelial Tube Formation by Modulating the Secretome of Hypoxic lung cancer Cells-Possible Role of VEGF Downregulation.
Wittig F; Koch F; Pannenberg L; Bekeschus S; Ramer R; Hinz B
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255884
[TBL] [Abstract] [Full Text] [Related]
14. Iodoquinazoline-derived vegfr-2 and EGFR
Mohamed AA; El-Hddad SSA; Aljohani AKB; Khedr F; Alatawi OM; Keshek DE; Ahmed S; Alsulaimany M; Almadani SA; El-Adl K; Hanafy NS
Bioorg Chem; 2024 Feb; 143():107062. PubMed ID: 38150938
[TBL] [Abstract] [Full Text] [Related]
15. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
16. Antiangiogenic Action of JZL184 on Endothelial Cells via Inhibition of VEGF Expression in Hypoxic lung cancer Cells.
Wittig F; Pannenberg L; Schwarz R; Bekeschus S; Ramer R; Hinz B
Cells; 2023 Sep; 12(19):. PubMed ID: 37830546
[TBL] [Abstract] [Full Text] [Related]
17. Efficacy and safety of immunotherapy combined with single-agent chemotherapy as second- or later-line therapy for metastatic non-small cell lung cancer.
Chen D; Li L; Wang M; Hu X; Jiang J; Li W; Yang L; Fan M; Shi Y; Lv F; Liu Y
Front Immunol; 2023; 14():1086479. PubMed ID: 37795095
[TBL] [Abstract] [Full Text] [Related]
18. The Effects of Drug Exposure and Single Nucleotide Polymorphisms on Aaptinib-Induced Severe Toxicities in Solid Tumors.
Chen Y; Lin Y; Guan S; Zhao Z; Lin D; Guan J; Zhou C; Liu J; Cao X; Lin Z; Chen D; Shang J; Zhang W; Chen H; Chen L; Ma S; Gu L; Zhao J; Huang M; Wang X; Long H
Drug Metab Dispos; 2023 Dec; 51(12):1583-1590. PubMed ID: 37775332
[TBL] [Abstract] [Full Text] [Related]
19. Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trial.
Corti F; Brizzi MP; Amoroso V; Giuffrida D; Panzuto F; Campana D; Prinzi N; Milione M; Cascella T; Spreafico C; Randon G; Oldani S; Leporati R; Scotto G; Pulice I; Stocchetti BL; Porcu L; Coppa J; Di Bartolomeo M; de Braud F; Pusceddu S
BMC Cancer; 2023 Sep; 23(1):908. PubMed ID: 37752423
[TBL] [Abstract] [Full Text] [Related]
20. In vivo self-assembly and delivery of vegfr2 siRNA-encapsulated small extracellular vesicles for lung metastatic osteosarcoma therapy.
Yu L; Fan G; Wang Q; Zhu Y; Zhu H; Chang J; Wang Z; Zhan S; Hua X; She D; Huang J; Wang Y; Zhao J; Zhang CY; Chen X; Zhou G
Cell Death Dis; 2023 Sep; 14(9):626. PubMed ID: 37739958
[TBL] [Abstract] [Full Text] [Related]
[Next]
